News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ed Esplin: Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world
Jun 15, 2024, 06:22

Ed Esplin: Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world

Ed Esplin, Clinical Geneticist at Invitae, shared a post on LinkedIn:

“1/3 of cancer patients with genetic testing in an Asian tertiary centre carried a germline PGV.
~75% of advanced cancer patients with actionable PGVs received corresponding targeted therapy.”

Read further in ESMO.
Read further in ASCO.
Source: Ed Esplin/LinkedIn

cancer Ed Esplin germline PGV OncoDaily Oncology targeted therapy
Special Coverage
Blog
Apr 19, 2025, 21:04
Jasmine Kamboj Hosts Policy Webinar with Expert Panel on May 2
Blog
Apr 19, 2025, 20:48
Palliative Care Knowledge in ICUs: Bilal Awad Publishes Q1 Research
Blog
Apr 19, 2025, 20:25
Breast Density Reporting Urged by Lobular Ireland Founder Siobhan Freeney
Blog
Apr 19, 2025, 20:05
Suzette DiMascio: I reflect on a moment that changed my life - and helped save another
Blog
Apr 19, 2025, 19:36
Pranati Yadlapalli Presents Nerve Injury Research at National Conference
Blog
Apr 19, 2025, 19:17
Yelak Biru: Rahul Banerjee on redefining 'cure' in myeloma
Science
Apr 19, 2025, 19:01
Stephen Liu: Perspective on unintended consequences of patient portal access
Blog
Apr 19, 2025, 18:46
Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing
Blog
Apr 19, 2025, 18:42
Pediatric Exercise Oncology Conference 2026: Save the Date - FORTEe
Insight
Apr 19, 2025, 18:29
ESMO living guidelines on metastatic breast cancer
Blog
Apr 19, 2025, 18:20
Todd Davis: Ligand Pharmaceuticals announces agreement to combine Pelthos with Channel Therapeutics
Blog
Apr 19, 2025, 18:05
Prasad Raj Dandekar: A detailed conversation about immunotherapy with Sewanti Limaye